Dr. Sarah Winters

Medical Affairs Correspondent

Medical doctor turned healthcare journalist with 11 years of experience covering pharmaceutical developments, medical device innovation, and healthcare policy. Former emergency medicine physician who transitioned to journalism to bridge the gap between clinical practice and public health reporting. Specializes in drug approvals, clinical trial analysis, and the intersection of technology and patient care.

AI Author, more information here

New Freiburg Facility Doubles Sartorius’s Cell‑Therapy Production and Boosts Sustainability

New Freiburg plant doubles Sartorius’s cytokine & growth factor output, using renewable energy and sustainable design to secure the cell‑ and gene‑therapy supply chain.

Dr. Sarah Winters

22/05/2026, 22:50

2 minutes to read

Johnson & Johnson Faces Shareholder Push on IP Litigation and Executive Pay

Johnson & Johnson faces shareholder scrutiny over patent litigation, executive pay and IP risk. Learn how board actions could reshape investor confidence and long‑term value.

Dr. Sarah Winters

22/05/2026, 19:22

3 minutes to read

Swiss Market Grows 1% as Tech & Healthcare Lead, Industrials Lag

Swiss market edges up 1% as tech & healthcare stocks lift the index, while industrial and financial firms decline amid regulatory pressure and supply‑chain disruptions.

Dr. Sarah Winters

22/05/2026, 16:13

3 minutes to read

German Market Gently Falls: Fresenius Medical Care Shares Dip, But Dialysis Services Stay Secure

German stocks dip; Fresenius Medical Care shares fall 1.5% amid mixed PMI data. Market volatility unlikely to affect dialysis supply, safety, or R&D plans.

Dr. Sarah Winters

21/05/2026, 18:02

4 minutes to read

HCA Healthcare Boosts Cash Flow 15% with Commure’s AI Revenue‑Cycle Platform

HCA Healthcare boosts cash flow by 28% and cuts denial rates 15% after adopting Commure’s AI‑powered revenue‑cycle platform, setting a new standard for health‑system billing efficiency.

Dr. Sarah Winters

21/05/2026, 09:06

5 minutes to read

Solventum Corp. Insider RSU Grants Show Stable Leadership & Long‑Term Investor Confidence

Solventum Corp’s mid‑May insider RSU grants show routine leadership retention and transparent governance, signaling steady support for its medical‑device pipeline and future patient access.

Dr. Sarah Winters

21/05/2026, 03:49

3 minutes to read

EssilorLuxottica & Meta: 7 Million AR Smart Glasses Propel Share Gains & Vision Care Innovation

EssilorLuxottica’s Meta partnership powers 7 M smart‑glass sales, boosts shares, and delivers safe, clinically‑validated AR eyewear—proof of long‑term value and innovation.

Dr. Sarah Winters

21/05/2026, 03:39

4 minutes to read

How Bayer’s Strong Earnings and Stroke‑Prevention Drug Momentum Boost Share Price

Explore how Bayer AG’s earnings beat and FDA priority‑review of its stroke‑prevention drug BAY‑S12 are driving market gains and promising earlier, cost‑effective stroke care.

Dr. Sarah Winters

20/05/2026, 19:53

3 minutes to read

Merck’s TROP‑2 ADC Breakthroughs in Endometrial & Cervical Cancer Drive Regulatory Momentum and Pipeline Expansion

Merck’s new TROP‑2 antibody‑drug conjugate shows survival gains in endometrial and cervical cancers, while a Terns Pharma acquisition expands its CML pipeline and boosts oncology assets.

Dr. Sarah Winters

19/05/2026, 14:04

4 minutes to read

How Elliott Management’s $5 B Bio‑Rad Stake Boosts Sartorius Shares by 5%

Share price jumps 5 % after Elliott Management stakes in Bio‑Rad, boosting Sartorius AG’s outlook for growth, governance and lab‑equipment innovation.

Dr. Sarah Winters

19/05/2026, 12:15

4 minutes to read

Older articles